Hosted on MSN
Innospec outlines margin improvement focus and expects operating income growth in 2026 despite Q1 weather impact
Patrick Williams, President and CEO, stated that "this was a good quarter for Innospec with continued strong operating income growth and margin expansion in Fuel Specialties, combined with improving ...
Hosted on MSN
Cencora outlines 11.5%-13.5% operating income growth for 2026 while integrating OneOncology
CEO Robert Mauch announced the completion of the acquisition of the majority of the remaining equity interest in OneOncology, emphasizing, "we are raising our fiscal 2026 guidance to reflect year-over ...
yoy = year-on-year, cc = at constant currency, EPS = earnings per share Click to enlarge FME Reignite set for next phase of value creation Fresenius Medical Care, the world's leading provider of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results